# OnCo record tropion-breast01 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/tropion-breast01/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "tropion-breast01", "NCT05104866" ;
  schema:name "TROPION-Breast01"@en ;
  schema:description "The trial that got Datroway approved in hormone-positive breast cancer, though it did not extend overall survival."@en ;
  schema:url <https://onco.cc/trials/tropion-breast01/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05104866> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  schema:startDate "2021-10-18" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/datopotamab-deruxtecan/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/>, <https://onco.cc/companies/daiichi-sankyo/> ;
  onco:people <https://onco.cc/people/aditya-bardia/>, <https://onco.cc/people/sara-tolaney/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-tropion-breast01-china-cohort-esmo-open-2026/> .